X scale titled Scale label.
Y scale titled Scale label.
Data series 1, Carboplatin / Cisplatin (Line).
Point 1, X=1991, Y=48.96617308, Carboplatin / Cisplatin, 1991 = 48.97.
Point 2, X=1996, Y=56.19795752, Carboplatin / Cisplatin, 1996 = 56.20.
Point 3, X=2002, Y=52.74278587, Carboplatin / Cisplatin, 2002 = 52.74.
Maximum at X=1996, Y=56.19795752 and minimum at X=1991, Y=48.96617308.
Data trends displayed in Graph:
1991-1996, APC = 2.79, Trend is characterized as NSC
1996-2002, APC = -1.05, Trend is characterized as NSC
Recent Trend: 1996-2002, AAPC = -1.05, Trend is characterized as NSC
Footnotes:
No HP 2010 Target.
Source: SEER based Patterns of Care Studies, Applied Research Program, National Cancer Institute. Data are age-adjusted based on the age distribution of ovarian cancer patients from 2001-2003 in the SEER 17 areas (http://seer.cancer.gov/registries/terms.html) using age groups: 20-24, 25-29, 30-34, 35-39, 40-44, 45-49, 50-54, 55-59, 60-64, 65-69, 70-74, 75-79, 80-84, 85+.
Trend lines connect sequential data points. Statistical significance of difference between sequential points was determined using a two-sample test incorporating the standard errors of the estimates.
The AAPC is the Average Annual Percent Change and is a weighted average of the APCs.
NSC: Non-Significant Change.